Skift (India) · 10 Jun 2026
Rajesh Magow frames MakeMyTrip as having already resolved the AI threat question — positioning its proprietary GenAI assistant Myra and OpenAI partnership as proof that discovery-layer disruption has been absorbed — while the India IPO remains structurally complex due to dual-listing restrictions and Mauritius incorporation, with the company running two parallel listed entities as a transitional structure.
Industry lens
Any OTA without a named, differentiated AI product faces a growing perception deficit as MMT consolidates the 'AI-native OTA' story ahead of a domestic listing that will generate sustained Indian media and investor coverage.
“MakeMyTrip is still weighing next steps for a domestic Indian IPO and thinks it has already won the AI debate.”
— Skift (India)